{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:34:17Z","timestamp":1787016857625,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"DOI":"10.1038\/s41389-026-00634-0","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:03:36Z","timestamp":1781190216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK"],"prefix":"10.1038","volume":"15","author":[{"given":"Jingwen","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-8541","authenticated-orcid":false,"given":"Yuchong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"634_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"634_CR2","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395:2008\u201320.","journal-title":"Lancet"},{"key":"634_CR3","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"634_CR4","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","volume":"21","author":"W Wei","year":"2020","unstructured":"Wei W, Zeng H, Zheng R, Zhang S, An L, Chen R, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020;21:e342\u20139.","journal-title":"Lancet Oncol"},{"key":"634_CR5","doi-asserted-by":"publisher","first-page":"e073995","DOI":"10.1136\/bmj-2022-073995","volume":"383","author":"M Del Chiaro","year":"2023","unstructured":"Del Chiaro M, Sugawara T, Karam SD, Messersmith WA. Advances in the management of pancreatic cancer. Bmj. 2023;383:e073995.","journal-title":"Bmj"},{"key":"634_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.667551","volume":"9","author":"X Chen","year":"2021","unstructured":"Chen X, Xie H, Wang X, Zheng Z, Jin S. CIRBP knockdown attenuates tumourigenesis and improves the chemosensitivity of pancreatic cancer via the downregulation of DYRK1B. Front Cell Dev Biol. 2021;9:667551.","journal-title":"Front Cell Dev Biol"},{"key":"634_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fonc.2014.00060","volume":"4","author":"S Terry","year":"2014","unstructured":"Terry S, Beltran H. The many faces of neuroendocrine differentiation in prostate cancer progression. Front Oncol. 2014;4:60.","journal-title":"Front Oncol"},{"key":"634_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/JTO.0000000000000034","volume":"9","author":"Y Chen","year":"2014","unstructured":"Chen Y, Nowak I, Huang J, Keng PC, Sun H, Xu H, et al. Erk\/MAP kinase signaling pathway and of non-small-cell lung cancer. J Thorac Oncol. 2014;9:50\u20138.","journal-title":"J Thorac Oncol"},{"key":"634_CR9","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1158\/0008-5472.CAN-21-0163","volume":"81","author":"C Enriquez","year":"2021","unstructured":"Enriquez C, Cancila V, Ferri R, Sulsenti R, Fischetti I, Milani M, et al. Castration-induced downregulation of SPARC in stromal cells drives neuroendocrine differentiation of prostate cancer. Cancer Res. 2021;81:4257\u201374.","journal-title":"Cancer Res"},{"key":"634_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41388-018-0461-3","volume":"38","author":"M Kato","year":"2019","unstructured":"Kato M, Placencio-Hickok VR, Madhav A, Haldar S, Tripathi M, Billet S, et al. Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner. Oncogene. 2019;38:716\u201330.","journal-title":"Oncogene"},{"key":"634_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","volume":"17","author":"\u00c1 Quintanal-Villalonga","year":"2020","unstructured":"Quintanal-Villalonga \u00c1, Chan JM, Yu HA, Pe\u2019er D, Sawyers CL, Sen T, et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat Rev Clin Oncol. 2020;17:360\u201371.","journal-title":"Nat Rev Clin Oncol"},{"key":"634_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01967-6","volume":"8","author":"AS Farrell","year":"2017","unstructured":"Farrell AS, Joly MM, Allen-Petersen BL, Worth PJ, Lanciault C, Sauer D, et al. MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. Nat Commun. 2017;8:1728.","journal-title":"Nat Commun"},{"key":"634_CR13","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00432-022-04061-7","volume":"148","author":"Y Xie","year":"2022","unstructured":"Xie Y, Ning S, Hu J. Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression. J Cancer Res Clin Oncol. 2022;148:1813\u201323.","journal-title":"J Cancer Res Clin Oncol"},{"key":"634_CR14","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1158\/0008-5472.CAN-17-2332","volume":"78","author":"Y Jung","year":"2018","unstructured":"Jung Y, Cackowski FC, Yumoto K, Decker AM, Wang J, Kim JK, et al. CXCL12\u03b3 promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypes. Cancer Res. 2018;78:2026\u201339.","journal-title":"Cancer Res"},{"key":"634_CR15","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1038\/onc.2017.50","volume":"36","author":"J Kim","year":"2017","unstructured":"Kim J, Jin H, Zhao JC, Yang YA, Li Y, Yang X, et al. FOXA1 inhibits prostate cancer neuroendocrine differentiation. Oncogene. 2017;36:4072\u201380.","journal-title":"Oncogene"},{"key":"634_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110240","volume":"91","author":"S Natani","year":"2022","unstructured":"Natani S, Sruthi KK, Asha SM, Khilar P, Lakshmi PSV, Ummanni R. Activation of TGF-\u03b2 - SMAD2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK. Cell Signal. 2022;91:110240.","journal-title":"Cell Signal"},{"key":"634_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.freeradbiomed.2010.10.715","volume":"50","author":"I Quiros-Gonzalez","year":"2011","unstructured":"Quiros-Gonzalez I, Sainz RM, Hevia D, Mayo JC. MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells. Free Radic Biol Med. 2011;50:525\u201336.","journal-title":"Free Radic Biol Med"},{"key":"634_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06177-2","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zheng D, Zhou T, Song H, Hulsurkar M, Su N, et al. Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nat Commun. 2018;9:4080.","journal-title":"Nat Commun"},{"key":"634_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352.","journal-title":"Nature"},{"key":"634_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/MPA.0000000000001319","volume":"48","author":"SH Lee","year":"2019","unstructured":"Lee SH, Jo JH, Kim YJ, Lee HS, Chung MJ, Park JY, et al. Plasma chromogranin a as a prognostic marker in pancreatic ductal adenocarcinoma. Pancreas. 2019;48:662\u20139.","journal-title":"Pancreas"},{"key":"634_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/carcin\/bgab097","volume":"43","author":"Z Luan","year":"2022","unstructured":"Luan Z, Morimoto Y, Fushimi A, Yamashita N, Suo W, Bhattacharya A, et al. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas. Carcinogenesis. 2022;43:67\u201376.","journal-title":"Carcinogenesis"},{"key":"634_CR22","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1158\/0008-5472.CAN-16-0899","volume":"77","author":"S Sinha","year":"2017","unstructured":"Sinha S, Fu YY, Grimont A, Ketcham M, Lafaro K, Saglimbeni JA, et al. PanIN neuroendocrine cells promote tumorigenesis via neuronal cross-talk. Cancer Res. 2017;77:1868\u201379.","journal-title":"Cancer Res"},{"key":"634_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18:99\u2013115.","journal-title":"Nat Rev Drug Discov"},{"key":"634_CR24","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med. 2023;55:1322\u201332.","journal-title":"Exp Mol Med"},{"key":"634_CR25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-10-1855","volume":"71","author":"S Dangi-Garimella","year":"2011","unstructured":"Dangi-Garimella S, Krantz SB, Barron MR, Shields MA, Heiferman MJ, Grippo PJ, et al. Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Cancer Res. 2011;71:1019\u201328.","journal-title":"Cancer Res"},{"key":"634_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1104-x","volume":"9","author":"L Wei","year":"2018","unstructured":"Wei L, Ye H, Li G, Lu Y, Zhou Q, Zheng S, et al. Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1\/SATB-1 pathway in pancreatic cancer. Cell Death Dis. 2018;9:1065.","journal-title":"Cell Death Dis"},{"key":"634_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03574-2","volume":"12","author":"L Wei","year":"2021","unstructured":"Wei L, Lin Q, Lu Y, Li G, Huang L, Fu Z, et al. Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-\u03b21\/SMAD2\/3 pathway and ABCC1 transactivation. Cell Death Dis. 2021;12:334.","journal-title":"Cell Death Dis"},{"key":"634_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12672-020-00381-7","volume":"11","author":"A Del Moral-Morales","year":"2020","unstructured":"Del Moral-Morales A, Gonz\u00e1lez-Orozco JC, Capetillo-Vel\u00e1zquez JM, Pi\u00f1a-Medina AG, Camacho-Arroyo I. The role of mPR\u03b4 and mPR\u03b5 in human glioblastoma cells: expression, hormonal regulation, and possible clinical outcome. Horm Cancer. 2020;11:117\u201327.","journal-title":"Horm Cancer"},{"key":"634_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.112032","volume":"575","author":"Z Li","year":"2023","unstructured":"Li Z, Lin Y, Zhuo S, Chen J, Chen L, Wang S, et al. PAQR9 regulates glucose homeostasis in diabetic mice and modulates insulin secretion in \u03b2 cells in vitro under stress conditions. Mol Cell Endocrinol. 2023;575:112032.","journal-title":"Mol Cell Endocrinol"},{"key":"634_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1210\/en.2012-1772","volume":"154","author":"Y Pang","year":"2013","unstructured":"Pang Y, Dong J, Thomas P. Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors \u03b4 and {epsilon} (mPR\u03b4 and mPR{epsilon}) and mPR\u03b4 involvement in neurosteroid inhibition of apoptosis. Endocrinology. 2013;154:283\u201395.","journal-title":"Endocrinology"},{"key":"634_CR31","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1073\/pnas.0436133100","volume":"100","author":"Y Zhu","year":"2003","unstructured":"Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA. 2003;100:2237\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"634_CR32","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1073\/pnas.0336132100","volume":"100","author":"Y Zhu","year":"2003","unstructured":"Zhu Y, Rice CD, Pang Y, Pace M, Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 2003;100:2231\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"634_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101331","volume":"53","author":"Y Lin","year":"2021","unstructured":"Lin Y, Chen L, You X, Li Z, Li C, Chen Y. PAQR9 regulates hepatic ketogenesis and fatty acid oxidation during fasting by modulating protein stability of PPAR\u03b1. Mol Metab. 2021;53:101331.","journal-title":"Mol Metab"},{"key":"634_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2015.11.011","volume":"29","author":"TK Hayes","year":"2016","unstructured":"Hayes TK, Neel NF, Hu C, Gautam P, Chenard M, Long B, et al. Long-term ERK inhibition in KRAS-mutant pancreatic cancer is associated with MYC degradation and senescence-like growth suppression. Cancer Cell. 2016;29:75\u201389.","journal-title":"Cancer Cell"},{"key":"634_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1158\/2159-8290.CD-20-0142","volume":"11","author":"MH Hofmann","year":"2021","unstructured":"Hofmann MH, Gmachl M, Ramharter J, Savarese F, Gerlach D, Marszalek JR, et al. BI-3406, a potent and selective SOS1-KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition. Cancer Discov. 2021;11:142\u201357.","journal-title":"Cancer Discov"},{"key":"634_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41591-018-0023-9","volume":"24","author":"S Mainardi","year":"2018","unstructured":"Mainardi S, Mulero-S\u00e1nchez A, Prahallad A, Germano G, Bosma A, Krimpenfort P, et al. SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo. Nat Med. 2018;24:961\u20137.","journal-title":"Nat Med"},{"key":"634_CR37","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41418-021-00880-2","volume":"29","author":"S Hu","year":"2022","unstructured":"Hu S, Ren S, Cai Y, Liu J, Han Y, Zhao Y, et al. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-\u03b2-catenin-STAT3 signaling. Cell Death Differ. 2022;29:642\u201356.","journal-title":"Cell Death Differ"},{"key":"634_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1677\/ERC-07-0061","volume":"14","author":"TC Yuan","year":"2007","unstructured":"Yuan TC, Veeramani S, Lin MF. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr Relat Cancer. 2007;14:531\u201347.","journal-title":"Endocr Relat Cancer"},{"key":"634_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216333","volume":"571","author":"S Naderinezhad","year":"2023","unstructured":"Naderinezhad S, Zhang G, Wang Z, Zheng D, Hulsurkar M, Bakhoum M, et al. A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression. Cancer Lett. 2023;571:216333.","journal-title":"Cancer Lett"},{"key":"634_CR40","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"634_CR41","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14827","volume":"11","author":"W Zhu","year":"2023","unstructured":"Zhu W, Huang M, Thakur A, Yan Y, Wu X. FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer. PeerJ. 2023;11:e14827.","journal-title":"PeerJ"},{"key":"634_CR42","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1158\/0008-5472.CAN-16-3143","volume":"77","author":"X Jin","year":"2017","unstructured":"Jin X, Pan Y, Wang L, Ma T, Zhang L, Tang AH, et al. Fructose-1,6-bisphosphatase inhibits ERK activation and bypasses gemcitabine resistance in pancreatic cancer by blocking IQGAP1-MAPK interaction. Cancer Res. 2017;77:4328\u201341.","journal-title":"Cancer Res"},{"key":"634_CR43","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-23-1200","volume":"84","author":"SP Singh","year":"2024","unstructured":"Singh SP, Dosch AR, Mehra S, De Castro Silva I, Bianchi A, Garrido VT, et al. Tumor cell-intrinsic p38 MAPK signaling promotes IL1\u03b1-mediated stromal inflammation and therapeutic resistance in pancreatic cancer. Cancer Res. 2024;84:1320\u201332.","journal-title":"Cancer Res"},{"key":"634_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0574-1","volume":"9","author":"Y Li","year":"2018","unstructured":"Li Y, Xi Z, Chen X, Cai S, Liang C, Wang Z, et al. Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src\/MAPK\/ERK pathways. Cell Death Dis. 2018;9:538.","journal-title":"Cell Death Dis"},{"key":"634_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1158\/1541-7786.MCR-21-0266","volume":"20","author":"M Kalli","year":"2022","unstructured":"Kalli M, Li R, Mills GB, Stylianopoulos T, Zervantonakis IK. Mechanical stress signaling in pancreatic cancer cells triggers p38 MAPK- and JNK-dependent cytoskeleton remodeling and promotes cell migration via Rac1\/cdc42\/Myosin II. Mol Cancer Res. 2022;20:485\u201397.","journal-title":"Mol Cancer Res"},{"key":"634_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/bs.pmbts.2017.03.004","volume":"148","author":"AM Knapinska","year":"2017","unstructured":"Knapinska AM, Estrada CA, Fields GB. The Roles of Matrix Metalloproteinases in Pancreatic Cancer. Prog Mol Biol Transl Sci. 2017;148:339\u201354.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"634_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.12.025","volume":"528","author":"P Nan","year":"2022","unstructured":"Nan P, Dong X, Bai X, Lu H, Liu F, Sun Y, et al. Tumor-stroma TGF-\u03b21-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin \u03b1(v)\u03b2(3)\/CD36-mediated activation of the MAPK pathway. Cancer Lett. 2022;528:59\u201375.","journal-title":"Cancer Lett"},{"key":"634_CR48","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2022.07.076","volume":"163","author":"J Datta","year":"2022","unstructured":"Datta J, Dai X, Bianchi A, De Castro Silva I, Mehra S, Garrido VT, et al. Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer. Gastroenterology. 2022;163:1593\u2013612.","journal-title":"Gastroenterology"},{"key":"634_CR49","doi-asserted-by":"crossref","unstructured":"Mucciolo G, Curcio C, Roux C, Li WY, Capello M, Curto R et al. IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions. Proc Natl Acad Sci USA 2021;118.","DOI":"10.1073\/pnas.2020395118"},{"key":"634_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06482-3","volume":"15","author":"W Chen","year":"2024","unstructured":"Chen W, Peng W, Wang R, Bai S, Cao M, Xiong S, et al. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells. Cell Death Dis. 2024;15:102.","journal-title":"Cell Death Dis"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00634-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00634-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00634-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:53:50Z","timestamp":1787014430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00634-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1038\/s41389-026-00634-0","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"44"}}